A subtle mutation in the type H collagen gene COL2AI was detected in a case of human hypochondrogenesis by using a chondrocyte culture system and PCR-cDNA scanning analysis. Chondrocytes obtained from cartilage biopsies were dedifferentiated and expanded in monolayer culture and then redifferentiated by culture over agarose. Single-strand conformation polymorphism and direct sequencing analysis identified a G --A transition, resulting in a glycine substitution at amino acid 574 of the proal(ll) collagen triple-helical domain. Morphologic assessment of cartilage-like structures produced in culture and electrophoretic analysis of collagens synthesized by the cultured chondrocytes suggested that the glycine substitution interferes with conversion of type II procollagen to collagen, impairs intracellular transport and secretion of the molecule, and disrupts collagen fibril assembly. This experimental approach has broad implications for the investigation of human chondrodysplasias as well as human chondrocyte biology.
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Chondrogenesis is responsible for the formation of the cartilage templates that serve as temporary models for the vertebrate skeleton. The process is crucial for the development of most embryonic bones and their subsequent linear growth-i.e., endochondral ossification. In both instances, this process involves the biosynthesis, secretion, and assembly of a highly ordered extracellular matrix by differentiated chondrocytes (1) . The ability of cartilage matrix to serve its template functions depends on its integrity, which in turn depends on the proper interactions between a threedimensional network of collagen fibrils comprised of type II collagen and lesser amounts of types IX and XI collagen and a host ofother matrix constituents, such as proteoglycans (2) .
Abnormalities of chondrogenesis and of the genes expressed during chondrogenesis, especially type II collagen, have long been suspected of causing certain of the human chondrodysplasias. Patients with chondrodysplasias typically have short, deformed bones that grow slowly (3) . Their clinical features vary widely and reflect the degree to which endochondral ossification and other normal cartilage functions are disturbed. The candidate disorders for mutations of COL2AJ, the gene encoding type II collagen, are the spondyloepiphyseal dysplasias (SEDs) (4, 5) . In these disorders the distribution of clinical disease parallels the distribution of type II collagen, defective chondrogenesis has been inferred from microscopic studies of growth plate and other cartilages (3, (6) (7) (8) , and electrophoretic abnormalities oftype II collagen have been found (5, (9) (10) (11) . Recently, reports of COL2AJ mutations in patients with SED have begun to emerge, validating the earlier suspicions (12) (13) (14) (15) (16) .
The detection of mutations in genes expressed during chondrogenesis remains difficult in humans. Cartilage is not easily accessible, and it is relatively acellular. Consequently, it is a poor source of RNA for cDNA synthesis and analysis. Even more problematic has been investigation of the consequences of mutations on chondrogenesis. Despite detailed knowledge of growth plate morphology (17) , there is a dearth of biologic information about endochondral ossification in humans. Furthermore, experimental models for studying chondrogenesis in humans are generally not available. Chondrocytes cultured under usual conditions lose their phenotypic characteristics and cease to express many of the genes normally expressed during chondrogenesis (18) . Thus, even when a mutation is identified, its biologic significance is difficult to determine.
To circumvent these technical problems and facilitate characterization of chondrogenesis mutations, we developed an experimental approach based on analysis of the products of cultured chondrocytes from affected patients. The plasticity of the chondrocyte phenotype was exploited to expand the population of cultured chondrocytes and to promote chondrogenesis in vitro. The mutation was detected by scanning analysis of COL2A1 cDNA derived from reversetranscribed RNA extracted from cultured chondrocytes, rather than by direct analysis of genomic DNA. We used the approach to identify a COL2AJ mutation and examine its effects on chondrogenesis in a case of human hypochondrogenesis.
METHODS
Cell Culture. Epiphyseal chondrocytes were obtained from costal cartilage at autopsy from an infant with radiographic characteristics of hypochondrogenesis. Control epiphyseal chondrocytes were obtained similarly from infants who showed no evidence of skeletal abnormalities.
The methods for chondrocyte isolation and monolayer culture have been described in detail (19) . Briefly, the cartilage was trimmed to remove perichondrium, minced, and digested overnight with collagenase. The 30 ,000 x g for 1 hr, the supernate was dialyzed against 0.1 M acetic acid and lyophilized. Samples of the labeled collagens were dissolved in buffer containing SDS, electrophoresed under reduced conditions in a 69% polyacrylamide gel (PAGE), and analyzed by autofluorography.
Genonic DNA Analysis. Genomic DNA was isolated from cultured fibroblasts as described (21) . Ten micrograms of DNA was digested with EcoRI, fractionated by electrophoresis overnight on an 0.8% agarose gel, transferred to Hybond-N membrane (Amersham), and hybridized against [32P]dATP (800 ,Ci/mmol; 1 Ci = 37 GBq) nick-translated COL2A1 cDNA probes (HC-21 and HC-22) spanning the full-length type II collagen message (22) , as described elsewhere (21) .
PCR Amplification. Genomic PCR amplifications were as described with denaturation at 94°C for 1.5 min, annealing at 55°C for 2.5 min, and extension at 72°C for 3.5 min (12) . cDNA amplification of primary overlapping fragments was as described with denaturation at 94°C for 1.5 min, annealing at 55°C for 2.5 min, and extension at 72°C for 2 min (23).
Amplification of cDNA subfragments in the single-strand conformation polymorphism (SSCP) analysis was as above, except for extension at 72°C for 0.5 min (24) . Oligonucleotide primers used in detecting the mutation are as listed: 5'-TCCTTTAGGACCAGTCACTCCAGTAGGACC-3', exon 38; 5'-GGGCCCAAAGGCGACAGG-3', exon 32; 5'-TCCACCATCCTTTCCAGGGGC-3', exon 33; 5'-GC-CCAGGGCCTCCAGGGTCCC-3', exon 31; 5'-CCCAG-CAGTCCAGCAGCC-3', intervening sequence 33.
RNA/cDNA Analysis. Total cellular RNA was extracted from the tissue-like, chondrocyte aggregate structures formed in agarose culture. Seven-to ten-day structures (20 mg) were lysed in guanidine isothiocyanate, and the RNA was isolated and purified by centrifugation on a CsCl2 gradient (21 Cloning and Sequencing. Direct sequencing of cDNA and genomic PCR amplification products were done as described (25) . cDNA and genomic PCR amplification products were cloned into the Sma I site of pUC18 and sequenced by the dideoxynucleotide chain-termination method. [7] [8] [9] [10] days they appeared similar to intact cartilage from the infant. Light microscopy showed a decrease in the relative amount of matrix (data not shown), which was confirmed by low-magnification TEM (Fig. 1A) . The greatest resemblance between the intact cartilage and the culture-derived structures was seen at higher magnification. In both instances the rER was distended with finely granular material in most chondrocytes (Fig. 1D) , and the collagen fibrils were thick and unevenly distributed (Fig.  1G) . Although the extent ofthese changes varied slightly, they were found in almost all fields of several structures examined. The ratio ofcollagen fibrils to proteoglycan granules appeared reduced in the hypochondrogenesis cultures compared with the controls, but this was not quantitated. The morphology of the control aggregate structures at 7-10 days was essentially that of normal cartilage, as shown for comparison in Fig. 1 B, E, and H.
RESULTS
Collagen Biosynthetic Analysis. PAGE of labeled collagens from control and hypochondrogenesis culture-derived structures is shown in Fig. 2A (lanes 1-3) . The electrophoretic pattern exhibited by the latter was abnormal. At the al position were two bands of equal intensity: one with normal mobility and another with slightly slower mobility. Most label was found in other slower migrating bands, which were not identified but had mobilities expected for proal(II) chain and incompletely processed proal(II) chains. The position of these chains was estimated from an experiment in which control cells were or were not treated with ascorbic acid [see PAGE of collagens in Fig. 2A (lanes 4 and 5) ].
Analysis of Mutation. Southern blot analysis of EcoRI digests of genomic DNA from the patient showed fragments of expected size that did not differ from control DNA (data not shown). Northern blot analysis of RNA isolated from the patient's cultured chondrocytes revealed a single COL2A1 [A and B, x500; C-E, x1380 (Insets, x5500); F-H, x5500.] mRNA transcript =5.0 kilobases (kb) in size, which did not differ from control transcripts (Fig. 2B) .
SSCP analysis of PCR-amplified subfragments from the three overlapping COL2A1 cDNAs suggested an allelic heterozygosity in the region spanning exons 31-33 and 32-38 (Fig. 3) . Direct sequencing of this region revealed a heterozygous G -3 A transition in exon 33 resulting in a Gly -. Ser substitution at residue 574 of the proal(II) triple-helical domain (Fig. 4 A Left) . Subsequently, a 2.5-kb fragment spanning exons 32-38 was amplified from patient's genomic DNA. Direct sequencing of exon 33 revealed the same G/A heterozygosity (Fig. 4 B Left) . The G/A heterozygosity was confirmed on both the cDNA and genomic level by cloning and sequencing of each allelic product (Fig. 4 A and The conditions used here were similar to a previously published method (19) , except that the cells were suspended over rather than in agarose. This was an important difference because it promoted cell aggregation and the formation of tissue-like structures that could be analyzed by established techniques. These synthesizing cDNA from culture-derived total cellular RNA and analyzing it by PCR-based methods was straightforward and much more efficient. The full-length human COL2A1 cDNA is only -5 kb compared with the 38-kb human COL2AI gene (26) . The cDNA was readily analyzed by PCR amplification of three overlapping fragments, SSCP analysis, and direct sequencing. Chan and Cole (27) (28) . Review of such mutations of type I collagen genes in osteogenesis imperfecta has suggested a relationship between the mutation site and the resulting clinical phenotype (29) . The closer the mutation is to the carboxyl terminus of the triple helix, the more severe the phenotype. Because the helix folds in a carboxyl-toamino direction, it has been postulated that glycine substitutions near the carboxyl terminus disrupt folding more than those at the amino terminus in a graded fashion. However, as exceptions to this rule increase, it is becoming evident that additional factors must also contribute to the severity of the resulting clinical phenotype (30) (31) (32) . This conclusion is underscored by the three Gly-* Ser substitutions now identified in COL2A1 (13, 27 The electrophoretic studies further support defective conversion of type II procollagen to collagen. Compared to control cultures in which almost all the 24-hr proline label migrated in the al(II) position by PAGE, a much smaller proportion of the label was found in this position in cultures from the case. The bulk ofthe label was found in bands having the mobility of proal(II) chain and processing intermediates. We were unable to obtain sufficient culture-derived collagen from this case to confirm this or exclude that these bands were derived from other procollagen types by twodimensional gel electrophoresis of cyanogen bromide peptides. However, strong indirect evidence was provided by experiments in which electrophoretic bands of comparable mobility were observed when control chondrocytes were cultured in the absence of ascorbic acid, which is known to disrupt post-translational processing of procollagen chains.
Glycine substitutions in al(I) chains that cause osteogenesis imperfecta are usually associated with overmodification of the majority the al(I) chains detected electrophoretically (33) (34) (35) . This situation reflects the stoichiometry of the molecule-i.e., at least one mutant chain is present in threefourths of procollagen molecules. The stoichiometry of type II procollagen predicts that seven-eighths of the molecules would contain at least one mutant al(II) for heterozygous mutations of COL2AL. Such overmodification has been demonstrated in several cases of moderate-to-severe SED (11) ; however, this overmodification was not seen in this case. A putative overmodified al(II) chain with slightly slower electrophoretic mobility was seen, but it was essentially the same intensity as the normally migrating al(II) chain. If it were an overmodified al(II) chain, the finding implies either that fewer of the mutant proa(II) chains were incorporated into procollagen molecules than predicted or that many overmodified proal(II) molecules were not processed to collagen molecules. The latter possibility seems much more likely, given the rER distention and electrophoretic observations. Structurally abnormal collagen fibrils were found in both intact cartilage and culture-derived structures from our case. Because we biochemically analyzed collagens from the entire cartilage-like structures without distinguishing between their intracellular and extracellular origin, the extent to which collagen molecules containing the mutant a chains were incorporated into these fibrils is not known. The abnormal fibrils could, therefore, reflect the direct effects of abnormal type II collagen molecules on fibril assembly, the effects of a diminished amount of normal type II collagen molecules relative to types IX and XI collagen molecules on this process, or some combination.
In summary, our findings indicate that a heterozygous G A transition in COL2AJ caused a glycine substitution in the middle of the type II collagen triple helix. This substitution appears to have interfered with the conversion of type II procollagen to collagen, impaired the intracellular transport and secretion of the molecule, and disrupted the extracellular assembly of cartilage collagen fibrils. The net effect was apparently a quantitatively deficient and qualitatively defective cartilage matrix that functioned poorly as a template for embryonic bone formation and subsequent linear bone growth. The experimental approach used in this investigation differed from previous approaches and provided the means not only to detect the mutation but also to examine its effects on type II collagen synthesis and on chondrogenesis, in general. The approach should be applicable to the investigation of a wide variety of defects of chondrogenesis.
